Whilst more people than ever before are surviving cancer, steps made towards improving early diagnosis and treatment were hampered by the pandemic. With record high referral levels, the target of returning to pre-Covid performance levels in 2023, set against the new Faster Diagnostic Standard target, is considered ambitious, and there is little chance of achieving these without private sector support and expertise.
The formation of cancer alliances is testament to the fact that collaboration provides the key to realising many of the NHS’s ambitions in cancer service delivery. Cross-sector partnerships are being forged across the country to improve screening programmes, give people faster access to diagnostic tests, capitalise on cutting-edge treatments and technologies, and ensure patients benefit from precise, highly personalised treatments.
This award will recognise projects and partnerships that are tangibly improving cancer outcomes at a local, regional or national level. Judges will be particularly interested in projects, improvements and innovations that have been genuinely co-produced by the NHS and private sector. These will have involved close consultation with patients and achieved high levels of staff engagement.
- This award is open to any private sector organisation which works in partnership with an NHS organisation or within a cancer alliance
- These can be single partnerships or joint working projects, but must demonstrate evidence from the past two years up until the awards deadline date